procyanidin has been researched along with Adverse Drug Event in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ojukwu, MO; Olaku, OO; White, JD; Zia, FZ | 1 |
| Cottreau, J; Crutchley, R; Garey, KW; Tucker, A | 1 |
| Bagchi, D; Bagchi, M; Preuss, HG; Ray, SD; Stohs, SJ | 1 |
| Bagchi, D; Bagchi, M; Patel, D; Ray, SD | 1 |
| Bagchi, D; Bagchi, M; Raje, RR; Ray, SD; Rinkovsky, A; Wong, V | 1 |
2 review(s) available for procyanidin and Adverse Drug Event
| Article | Year |
|---|---|
The Role of Grape Seed Extract in the Treatment of Chemo/Radiotherapy Induced Toxicity: A Systematic Review of Preclinical Studies.
Topics: Animals; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Grape Seed Extract; Mice; Proanthocyanidins; Radiation Injuries, Experimental; Rats; Rats, Sprague-Dawley; Rats, Wistar | 2015 |
Crofelemer for the treatment of secretory diarrhea.
Topics: Antidiarrheals; Chloride Channels; Cystic Fibrosis Transmembrane Conductance Regulator; Diarrhea; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Proanthocyanidins; Travel | 2012 |
3 other study(ies) available for procyanidin and Adverse Drug Event
| Article | Year |
|---|---|
Mechanistic pathways of antioxidant cytoprotection by a novel IH636 grape seed proanthocyanidin extract.
Topics: Acetaminophen; Administration, Oral; Alanine Transaminase; Amiodarone; Analgesics, Non-Narcotic; Animals; Antineoplastic Agents; Antioxidants; Apoptosis; Blood Urea Nitrogen; Cell Cycle; Creatine Kinase; Dimethylnitrosamine; DNA Damage; Doxorubicin; Drug-Related Side Effects and Adverse Reactions; Free Radical Scavengers; Grape Seed Extract; Heart Diseases; Humans; In Vitro Techniques; Injections, Intraperitoneal; Keratinocytes; Kidney Diseases; Lipid Peroxidation; Lung Diseases; Mice; Mice, Inbred ICR; Necrosis; Oxidation-Reduction; Plant Extracts; Proanthocyanidins; Spleen; Tobacco, Smokeless; Vasodilator Agents | 2002 |
Protection against drug- and chemical-induced multiorgan toxicity by a novel IH636 grape seed proanthocyanidin extract.
Topics: Alanine Transaminase; Animals; Antioxidants; Biological Availability; Cardiovascular Diseases; Chemical and Drug Induced Liver Injury; DNA Damage; DNA Fragmentation; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Female; Free Radical Scavengers; Grape Seed Extract; Humans; Kidney Diseases; Liver Diseases; Lung Diseases; Male; Mice; Plant Extracts; Proanthocyanidins; Spleen | 2001 |
Unique organoprotective properties of a novel IH636 grape seed proanthocyanidin extract on cadmium chloride-induced nephrotoxicity, dimethylnitrosamine (DMN)-induced splenotoxicity and mocap-induced neurotoxicity in mice.
Topics: Activins; Administration, Oral; Alanine Transaminase; Animals; Apoptosis; Biological Availability; Cadmium Chloride; Creatine Kinase; Dimethylnitrosamine; DNA Fragmentation; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Grape Seed Extract; Injections, Intraperitoneal; Kidney Diseases; Male; Mice; Mice, Inbred ICR; Necrosis; Nervous System Diseases; Organothiophosphates; Plant Extracts; Proanthocyanidins; Spleen | 2000 |